BONVINI, PAOLO

BONVINI, PAOLO  

Dipartimento di Salute della Donna e del Bambino - SDB  

Mostra records
Risultati 1 - 18 di 18 (tempo di esecuzione: 0.046 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
3D extracellular matrix derived model of alveolar rhabdomyosarcoma 2019 Mattia SaggioroStefania D’AgostinoElena PoliPaolo BonviniGianni BisognoPiergiorgio GambaMichela Pozzobon + - - TERMIS EU 2019 Conference Book
A 3D model for the study of the role of glypican 3 in rhabdomyosarcoma progression 2020 D’Agostino S.Poli E.Tombolan L.Del Vecchio C.Parolin M. C.Bonvini P.Pozzobon M + - - EACR-AACR Basic Translational Research Conference Abstract Book
ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors. 2015 LOVISA, FEDERICACOZZA, GIORGIOCUZZOLIN, ALBERTOMUSSOLIN, LARAPILLON, MARTAMORO, STEFANOBASSO, GIUSEPPEROSOLEN, ANGELOBONVINI, PAOLO + PLOS ONE - PloS one
Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma 2016 ALAGGIO, RITAZIN, ANGELICABONVINI, PAOLOBISOGNO, GIANNIDAIDONE, MARIA GRAZIA + ONCOTARGET - -
Autoantibody profiling of alveolar rhabdomyosarcoma patients unveils tumor-associated antigens with diagnostic and prognostic significance 2021 Poli E.Cattelan M.Zin A.Bisogno G.Bonvini P. + ONCOIMMUNOLOGY - -
Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor 2021 Bonvini P.Zin A.Tombolan L.Affinita M. C.Santoro L.Bisogno G. + FRONTIERS IN PEDIATRICS - -
Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma 2020 Tombolan, LMillino, CPacchioni, BCattelan, MZin, ABonvini, PBisogno, G FRONTIERS IN GENETICS - -
Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma 2017 Pomari, ElenaLovisa, FedericaD'Amore, Emanuele S. G.Bonvini, PaoloPillon, MartaBasso, GiuseppeBasso, KatiaMussolin, Lara + ONCOTARGET - -
Clinical significance of circulating tumor cells and cell-free DNA in pediatric rhabdomyosarcoma 2022 Tombolan, LuciaRossi, ElisabettaBinatti, AndreaZin, AngelicaManicone, MariangelaFacchinetti, AntonellaLucchetta, SilviaAffinita, Maria CarmenBonvini, PaoloBortoluzzi, StefaniaBisogno, Gianni + MOLECULAR ONCOLOGY - -
Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application. 2006 COZZA, GIORGIOBONVINI, PAOLOZORZI, ELISAPOLETTO, GIORGIAPAGANO, MARIO ANGELO PRIMOSARNO, STEFANIADONELLA, ARIANNAZAGOTTO, GIUSEPPEROSOLEN, ANGELOPINNA, LORENZOMEGGIO, FLAVIOMORO, STEFANO JOURNAL OF MEDICINAL CHEMISTRY - -
Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness 2022 Lucchetta S.Santoro L.Bisogno G.Bonvini P. + ONCOIMMUNOLOGY - -
Impatto clinico della soppressione di SIK1 da parte di miR-223 in pazienti pediatrici affetti da linfoma linfoblastico T 2017 Pomari ELovisa FD’Amore ESGBonvini PDE VITO, ROBERTAVINTI, PIETRO LEONE GIOVANNIBASSO, KATIAMussolin L. + HEMATOLOGY REPORTS - -
Liquid biopsy in pediatric renal cancer: Stage I and stage IV cases compared 2020 Tombolan L.Affinita M. C.Bonvini P.Schiavi F.Bisogno G. + DIAGNOSTICS - -
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study 2022 Tombolan, LuciaPace, ErikaBonvini, PaoloBisogno, Gianni + JCO PRECISION ONCOLOGY - -
Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner 2020 Tombolan L.Zin A.Santoro L.Bonvini P.Bisogno G. + TRANSLATIONAL ONCOLOGY - -
Rhabdomyosarcoma Cells Produce Their Own Extracellular Matrix With Minimal Involvement of Cancer-Associated Fibroblasts: A Preliminary Study 2021 D’Agostino, StefaniaTombolan, LuciaSaggioro, MattiaFrasson, ChiaraRampazzo, ElenaPellegrini, StefaniaFavaretto, FrancescaBiz, CarloRuggieri, PietroGamba, PiergiorgioBonvini, PaoloAveic, SanjaPozzobon, Michela + FRONTIERS IN ONCOLOGY - -
Understanding the interplay between expression, mutation and activity of ALK receptor in Rhabdomyosarcoma cells for clinical application of small-molecule inhibitors 2015 PERON, MARICALOVISA, FEDERICAPOLI, ELENABASSO, GIUSEPPEBONVINI, PAOLO PLOS ONE - -
Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitors. 2011 COZZA, GIORGIOGIANONCELLI, ALESSANDRABONVINI, PAOLOZORZI, ELISAPASQUALE, RICCARDOROSOLEN, ANGELOPINNA, LORENZOMEGGIO, FLAVIOZAGOTTO, GIUSEPPEMORO, STEFANO CHEMMEDCHEM - -